Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 130

1.

Electron microscopic, genetic and protein expression analyses of Helicobacter acinonychis strains from a Bengal tiger.

Tegtmeyer N, Rivas Traverso F, Rohde M, Oyarzabal OA, Lehn N, Schneider-Brachert W, Ferrero RL, Fox JG, Berg DE, Backert S.

PLoS One. 2013 Aug 5;8(8):e71220. doi: 10.1371/journal.pone.0071220. Print 2013.

2.

Randomized trial on 14 versus 7 days of esomeprazole, moxifloxacin, and amoxicillin for second-line or rescue treatment of Helicobacter pylori infection.

Miehlke S, Krasz S, Schneider-Brachert W, Kuhlisch E, Berning M, Madisch A, Laass MW, Neumeyer M, Jebens C, Zekorn C, Knoth H, Vieth M, Stolte M, Lehn N, Morgner A.

Helicobacter. 2011 Dec;16(6):420-6. doi: 10.1111/j.1523-5378.2011.00867.x.

PMID:
22059392
3.

Integrity of proteins in human saliva after sterilization by gamma irradiation.

Ruhl S, Berlenbach P, Langenfelder S, Hörl D, Lehn N, Hiller KA, Schmalz G, Durchschlag H.

Appl Environ Microbiol. 2011 Feb;77(3):749-55. doi: 10.1128/AEM.01374-10. Epub 2010 Dec 10.

4.

Helicobacter pylori in human oral cavity and stomach.

Bürgers R, Schneider-Brachert W, Reischl U, Behr A, Hiller KA, Lehn N, Schmalz G, Ruhl S.

Eur J Oral Sci. 2008 Aug;116(4):297-304. doi: 10.1111/j.1600-0722.2008.00543.x.

PMID:
18705796
5.

Extensively drug resistant tuberculosis in a high income country: a report of four unrelated cases.

Blaas SH, Mütterlein R, Weig J, Neher A, Salzberger B, Lehn N, Naumann L.

BMC Infect Dis. 2008 May 2;8:60. doi: 10.1186/1471-2334-8-60.

6.

Tissue concentrations of vancomycin and Moxifloxacin in periprosthetic infection in rats.

Beckmann J, Kees F, Schaumburger J, Kalteis T, Lehn N, Grifka J, Lerch K.

Acta Orthop. 2007 Dec;78(6):766-73. doi: 10.1080/17453670710014536.

PMID:
18236182
7.

One-week once-daily triple therapy with esomeprazole, moxifloxacin, and rifabutin for eradication of persistent Helicobacter pylori resistant to both metronidazole and clarithromycin.

Miehlke S, Schneider-Brachert W, Kirsch C, Morgner A, Madisch A, Kuhlisch E, Haferland C, Bästlein E, Jebens C, Zekorn C, Knoth H, Stolte M, Lehn N.

Helicobacter. 2008 Feb;13(1):69-74. doi: 10.1111/j.1523-5378.2007.00588.x.

PMID:
18205669
8.

Management of a large healthcare-associated outbreak of Panton-Valentine leucocidin-positive meticillin-resistant Staphylococcus aureus in Germany.

Wagenlehner FM, Naber KG, Bambl E, Raab U, Wagenlehner C, Kahlau D, Höller C, Witte W, Weidner W, Lehn N, Harbarth S, Linde HJ.

J Hosp Infect. 2007 Oct;67(2):114-20. Epub 2007 Sep 27.

PMID:
17900757
9.

Comparison of the pharmacokinetics of piperacillin and sulbactam during intermittent and continuous intravenous infusion.

Langgartner J, Lehn N, Glück T, Herzig H, Kees F.

Chemotherapy. 2007;53(5):370-7. Epub 2007 Sep 3.

PMID:
17785973
10.

Rapid detection of Panton-Valentine leukocidin-positive Staphylococcus aureus by real-time PCR targeting the lukS-PV gene.

Reischl U, Tuohy MJ, Hall GS, Procop GW, Lehn N, Linde H.

Eur J Clin Microbiol Infect Dis. 2007 Feb;26(2):131-5.

PMID:
17256113
11.

[Beta-lactam resistance hits virulence. Methicillin resistant Staphylococcus aureus].

Linde HJ, Lehn N.

Pharm Unserer Zeit. 2006;35(5):422-5. Review. German. No abstract available.

PMID:
17009786
12.

Randomized trial of rifabutin-based triple therapy and high-dose dual therapy for rescue treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin.

Miehlke S, Hansky K, Schneider-Brachert W, Kirsch C, Morgner A, Madisch A, Kuhlisch E, Bästlein E, Jacobs E, Bayerdörffer E, Lehn N, Stolte M.

Aliment Pharmacol Ther. 2006 Jul 15;24(2):395-403.

13.

Moxifloxacin superior to vancomycin for treatment of bone infections--a study in rats.

Kalteis T, Beckmann J, Schröder HJ, Handel M, Grifka J, Lehn N, Lerch K.

Acta Orthop. 2006 Apr;77(2):315-9.

PMID:
16752296
14.

Treatment of implant-associated infections with moxifloxacin: an animal study.

Kalteis T, Beckmann J, Schröder HJ, Schaumburger J, Linde HJ, Lerch K, Lehn N.

Int J Antimicrob Agents. 2006 May;27(5):444-8. Epub 2006 Apr 18.

PMID:
16621461
15.

Helicobacter pylori as a prognostic indicator after curative resection of gastric carcinoma: a prospective study.

Meimarakis G, Winter H, Assmann I, Kopp R, Lehn N, Kist M, Stolte M, Jauch KW, Hatz RA.

Lancet Oncol. 2006 Mar;7(3):211-22.

PMID:
16510330
16.

Prevalence of and risk factors for carriage of Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus among residents and staff of a German nursing home.

Raab U, Kahlau D, Wagenlehner F, Reischl U, Ehrenstein V, Lehn N, Holler C, Linde HJ.

Infect Control Hosp Epidemiol. 2006 Feb;27(2):208-11. Epub 2006 Feb 8.

PMID:
16465643
17.

Healing of lymphocytic gastritis after Helicobacter pylori eradication therapy--a randomized, double-blind, placebo-controlled multicentre trial.

Madisch A, Miehlke S, Neuber F, Morgner A, Kuhlisch E, Rappel S, Lehn N, Bayerdörffer E, Seitz G, Stolte M.

Aliment Pharmacol Ther. 2006 Feb 15;23(4):473-9.

18.

7-day triple therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and high-dose esomeprazole in patients with known antimicrobial sensitivity.

Antos D, Schneider-Brachert W, Bästlein E, Hänel C, Haferland C, Buchner M, Meier E, Trump F, Stolte M, Lehn N, Bayerdörffer E.

Helicobacter. 2006 Feb;11(1):39-45.

PMID:
16423088
19.
20.

Contaminant seeding in bone by different irrigation methods: an experimental study.

Kalteis T, Lehn N, Schröder HJ, Schubert T, Zysk S, Handel M, Grifka J.

J Orthop Trauma. 2005 Oct;19(9):591-6.

PMID:
16247302
21.

[Infections with methicillin-resistant Staphylococcus aureus: impact of Panton-Valentine leukocidin].

Linde H, Lehn N.

Dtsch Med Wochenschr. 2005 Oct 21;130(42):2397-401. Review. German. No abstract available.

PMID:
16235149
22.

Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus in Germany associated with travel or foreign family origin.

Maier J, Melzl H, Reischl U, Drubel I, Witte W, Lehn N, Linde H.

Eur J Clin Microbiol Infect Dis. 2005 Sep;24(9):637-9. No abstract available.

PMID:
16167136
23.

Characterization of the Helicobacter pylori cysteine-rich protein A as a T-helper cell type 1 polarizing agent.

Deml L, Aigner M, Decker J, Eckhardt A, Schütz C, Mittl PR, Barabas S, Denk S, Knoll G, Lehn N, Schneider-Brachert W.

Infect Immun. 2005 Aug;73(8):4732-42.

24.

[Antibacterial photodynamic therapy. A new treatment for superficial bacterial infections?].

Maisch T, Szeimies RM, Lehn N, Abels C.

Hautarzt. 2005 Nov;56(11):1048-55. Review. German.

PMID:
15997402
25.

Impact of Helicobacter pylori virulence factors and compounds on activation and maturation of human dendritic cells.

Kranzer K, Söllner L, Aigner M, Lehn N, Deml L, Rehli M, Schneider-Brachert W.

Infect Immun. 2005 Jul;73(7):4180-9.

26.

Development of a real-time PCR assay for rapid identification of methicillin-resistant Staphylococcus aureus from clinical samples.

Hagen RM, Seegmüller I, Navai J, Kappstein I, Lehn N, Miethke T.

Int J Med Microbiol. 2005 Jun;295(2):77-86.

PMID:
15969468
27.

Healthcare-associated outbreaks and community-acquired infections due to MRSA carrying the Panton-Valentine leucocidin gene in southeastern Germany.

Linde H, Wagenlehner F, Strommenger B, Drubel I, Tanzer J, Reischl U, Raab U, Höller C, Naber KG, Witte W, Hanses F, Salzberger B, Lehn N.

Eur J Clin Microbiol Infect Dis. 2005 Jun;24(6):419-22.

PMID:
15937659
28.
29.

Photodynamic effects of novel XF porphyrin derivatives on prokaryotic and eukaryotic cells.

Maisch T, Bosl C, Szeimies RM, Lehn N, Abels C.

Antimicrob Agents Chemother. 2005 Apr;49(4):1542-52.

30.

Green fluorescent protein for detection of the probiotic microorganism Escherichia coli strain Nissle 1917 (EcN) in vivo.

Schultz M, Watzl S, Oelschlaeger TA, Rath HC, Göttl C, Lehn N, Schölmerich J, Linde HJ.

J Microbiol Methods. 2005 Jun;61(3):389-98.

PMID:
15767015
31.

[Methicillin-resistant Staphylococcus aureus (MRSA) -- therapy and hygienic measures].

Linde H, Lehn N.

Dtsch Med Wochenschr. 2005 Mar 18;130(11):586-8; quiz 589-92. Review. German. No abstract available.

PMID:
15761788
32.

[Methicillin-resistant Staphylococcus aureus (MRSA) -- diagnosis].

Linde H, Lehn N.

Dtsch Med Wochenschr. 2005 Mar 18;130(11):582-5; quiz 589-92. Review. German. No abstract available.

PMID:
15761787
33.

[Methicillin-resistant Staphylococcus aureus (MRSA) -- case report].

Linde H, Lehn N.

Dtsch Med Wochenschr. 2005 Mar 18;130(11):581; quiz 589-92. German. No abstract available.

PMID:
15761786
34.

Vibrio metschnikovii, a rare cause of wound infection.

Linde HJ, Kobuch R, Jayasinghe S, Reischl U, Lehn N, Kaulfuss S, Beutin L.

J Clin Microbiol. 2004 Oct;42(10):4909-11.

35.

Induction of maturation and cytokine release of human dendritic cells by Helicobacter pylori.

Kranzer K, Eckhardt A, Aigner M, Knoll G, Deml L, Speth C, Lehn N, Rehli M, Schneider-Brachert W.

Infect Immun. 2004 Aug;72(8):4416-23.

36.

Combined skin disinfection with chlorhexidine/propanol and aqueous povidone-iodine reduces bacterial colonisation of central venous catheters.

Langgartner J, Linde HJ, Lehn N, Reng M, Schölmerich J, Glück T.

Intensive Care Med. 2004 Jun;30(6):1081-8. Epub 2004 Apr 15.

PMID:
15085323
37.

Reliable detection of macrolide-resistant Helicobacter pylori via fluorescence in situ hybridization in formalin-fixed tissue.

Jüttner S, Vieth M, Miehlke S, Schneider-Brachert W, Kirsch C, Pfeuffer T, Lehn N, Stolte M.

Mod Pathol. 2004 Jun;17(6):684-9.

38.

Klebsiella oxytoca as an agent of antibiotic-associated hemorrhagic colitis.

Beaugerie L, Metz M, Barbut F, Bellaiche G, Bouhnik Y, Raskine L, Nicolas JC, Chatelet FP, Lehn N, Petit JC; Infectious Colitis Study Group.

Clin Gastroenterol Hepatol. 2003 Sep;1(5):370-6.

PMID:
15017655
39.

[Helicobacter treatment. Proven and new antibiotic combinations for the treatment of recurrences].

Bayerdörffer E, Lehn N, Stolte M.

Dtsch Med Wochenschr. 2004 Feb 27;129(9):443-6. Review. German. No abstract available.

PMID:
14970917
40.

Application of single-cell cultures of mouse splenocytes as an assay system to analyze the immunomodulatory properties of bacterial components.

Deml L, Aigner M, Eckhardt A, Decker J, Lehn N, Schneider-Brachert W.

Methods Mol Med. 2004;94:159-75.

PMID:
14959828
41.

Functional analysis of the cag pathogenicity island in Helicobacter pylori isolates from patients with gastritis, peptic ulcer, and gastric cancer.

Backert S, Schwarz T, Miehlke S, Kirsch C, Sommer C, Kwok T, Gerhard M, Goebel UB, Lehn N, Koenig W, Meyer TF.

Infect Immun. 2004 Feb;72(2):1043-56.

43.

Bacteria ingestion by blowfly larvae: an in vitro study.

Lerch K, Linde HJ, Lehn N, Grifka J.

Dermatology. 2003;207(4):362-6.

PMID:
14657627
44.

Identification of candidate antigens for serologic detection of Helicobacter pylori-infected patients with gastric carcinoma.

Krah A, Miehlke S, Pleissner KP, Zimny-Arndt U, Kirsch C, Lehn N, Meyer TF, Jungblut PR, Aebischer T.

Int J Cancer. 2004 Jan 20;108(3):456-63.

45.

Prosthetic joint infections with osteomyelitis due to Candida albicans.

Lerch K, Kalteis T, Schubert T, Lehn N, Grifka J.

Mycoses. 2003 Dec;46(11-12):462-6.

PMID:
14641618
46.

Esomeprazole-based one-week triple therapy with clarithromycin and metronidazole is effective in eradicating Helicobacter pylori in the absence of antimicrobial resistance.

Miehlke S, Schneider-Brachert W, Bästlein E, Ebert S, Kirsch C, Haferland C, Buchner M, Neumeyer M, Vieth M, Stolte M, Lehn N, Bayerdörffer E.

Aliment Pharmacol Ther. 2003 Oct 15;18(8):799-804.

47.

Pericarditis as primary manifestation of Mycobacterium bovis SSP. caprae infection.

Blaas SH, Böhm S, Martin G, Erler W, Glück T, Lehn N, Naumann L.

Diagn Microbiol Infect Dis. 2003 Oct;47(2):431-3.

PMID:
14522518
48.

Clinically significant borderline resistance of sequential clinical isolates of Klebsiella pneumoniae.

Wagenlehner FM, Heisig P, Irtenkauf C, Notka F, Decker J, Lehn N, Linde H.

Int J Antimicrob Agents. 2003 Oct;22(4):367-73.

PMID:
14522099
49.

A prospective, randomized study of quadruple therapy and high-dose dual therapy for treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin.

Miehlke S, Kirsch C, Schneider-Brachert W, Haferland C, Neumeyer M, Bästlein E, Papke J, Jacobs E, Vieth M, Stolte M, Lehn N, Bayerdörffer E.

Helicobacter. 2003 Aug;8(4):310-9.

PMID:
12950604
50.

Branched filaments no fungus, ovoid bodies no bacteria: Two unusual cases of mycetoma.

Douwes KE, Schmalzbauer E, Linde HJ, Reisberger EM, Fleischer K, Lehn N, Landthaler M, Vogt T.

J Am Acad Dermatol. 2003 Aug;49(2 Suppl Case Reports):S170-3.

PMID:
12894113

Supplemental Content

Support Center